Wall Street Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-160
Closed -$46.8K 275
2026
Q1
$46.8K Buy
+160
New +$52.6K 0.03% 328

Other funds holding ELV

Wall Street Financial Group's ELV Position: Q2 2026 in Review

Wall Street Financial Group sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 160 shares — an estimated $46.8K sold.

Wall Street Financial Group first reported a position in ELV in Q1 2026 and held it in 1 quarter. The position peaked at $46.8K in Q1 2026. 934 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Wall Street Financial Group reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Wall Street Financial Group sold 160 Elevance Health shares in Q2 2026, an estimated $46.8K.
  • Wall Street Financial Group first reported a position in Elevance Health in Q1 2026 and held it in 1 quarter.
  • Wall Street Financial Group's Elevance Health position peaked at $46.8K in Q1 2026.
  • 934 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.